Planned sale

Roivant Sciences (ROIV): Officer filed to sell ~$7.32M

Pulik Richard, Officer at Roivant Sciences, filed to sell ~$7.32M of Roivant Sciences shares.

~$7.32M
planned to sell · 175K shares, around Nov 11, 2026
Planned for
Nov 11, 2026
Notice filed
Nov 13, 2026

What stands out in this filing

  • The planned sale is 0.02% of the company's shares outstanding, as stated on the notice.
  • How the shares were acquired, per the notice: Restricted Stock Vesting Under a Registered Plan.
  • The notice says the shares were received as pay (stock awards or options).
  • Broker named on the notice: Morgan Stanley Smith Barney LLC.
  • Notice filed Nov 13, 2026 for a sale planned around Nov 11, 2026.
  • Remarks on the notice: This amendment is being filed to update the client's affiliation to the issuer and to update the Securities to be Sold Table. Sales that were executed on November 11, 2026 are being reported on this Form 144 filed on No.
  • A Form 144 announces a sale; the Form 4 that follows shows whether it took place, at what price.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 15, 2026Insider · 2 peopleInsiders: 4 sales (~$399K)
  2. Sep 30, 2026InsiderCEO sold ~$7.32M of ROIV shares in the open market
  3. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$641K)
  4. Oct 20, 2026Insider · 1 personInsiders: 2 sales (~$7.0M)
  5. Oct 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 8.2%
  6. Oct 28, 2026InsiderCEO sold ~$7.32M of ROIV shares in the open market
  7. Nov 3, 2026InsiderCEO sold ~$7.26M of ROIV shares in the open market
  8. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 11.8%
  9. Nov 9, 2026Company filing · Form 8-K · ResultsReported its results
  10. Nov 10, 2026Insider · 2 peopleInsiders: 3 sales (~$12.8M)
  11. Nov 11, 2026Insider · 1 personInsiders: 3 sales (~$7.3M)

What came next

  1. Nov 16, 2026Insider · 3 peopleInsiders: 12 sales (~$91.5M)
  2. Nov 17, 2026Insider · 3 peopleInsiders: 9 sales (~$69.1M)
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 58 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

How this filing works

Explore the data

Common questions

Which Roivant Sciences (ROIV) insider traded, and how much?

Pulik Richard, Officer at Roivant Sciences, filed to sell ~$7.32M of Roivant Sciences shares. 175K shares, Form 144 notice of a planned sale.

When did it happen, and when was it made public?

Planned for: Nov 11, 2026. Notice filed: Nov 13, 2026. That is 2 days between the two dates.

What stands out in this filing?

The planned sale is 0.02% of the company's shares outstanding, as stated on the notice. How the shares were acquired, per the notice: Restricted Stock Vesting Under a Registered Plan. The notice says the shares were received as pay (stock awards or options).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Roivant Sciences recently?

For Roivant Sciences, OQRO holds 58 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ROIV page.

Does this mean ROIV stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Roivant Sciences

Everything OQRO holds on this company is on its ROIV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data